Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SIGA · against 260 other Healthcare companies of similar size
Ranked #166 of 261 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score96 peers with a valuation score of 0–9, including SIGA · Click a bar to see the companies
Mainly because of its EBITDA yield, free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | SIGA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 244 reported | -1.3% | -0.9% | 48% | 30% | |
| EBITDA yieldHigher is better · 268 reported | -9.8% | 1.4% | 28% | 50% | |
| Free cash flow yieldHigher is better · 142 reported | -9.2% | -12.1% | 57% | 20% | |
| Book yieldHigher is better · 249 reported | 74.0% | 61.2% | 60% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 166 | 427M USD | 8 | 7 | |
| 166 | 421M USD | 8 | 52 | |
| 166 | 139M USD | 8 | 32 | |
| 166 | 388M USD | 8 | 36 | |
| 166 | 223M USD | 8 | 34 | |
| 166 | 303M USD | 8 | 27 | |
| 166 | 354M USD | 8 | 13 | |
| 166 | 172M USD | 8 | 34 | |
| 166 | 371M USD | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score